Fluoxymesterone is an extremely powerful anabolic androgenic steroid that was first released in the late 1950’s by Upjohn under the trade name Halotestin. Shortly after, Ciba Pharmaceuticals would release the hormone under the Ultandren name, but Halotestin has remained the most recognizable brand name. Pharmacia, formerly Upjohn, now manufactures the Halotestin brand name.
When Halotestin first hit the market, it was touted as holding numerous therapeutic benefits. This extremely potent anabolic steroid was prescribed for the treatment of muscle wasting, androgen deficiency in men, lean tissue repair, malnutrition, and for healing bone fractures. It would also be regularly used to treat prolonged exposure to cortisone, paraplegia, breast cancer and often given to burn victims. Unlike many anabolic steroids, Halotestin was regularly prescribed to men and women, and while its modern day use is somewhat limited it is still used to treat breast cancer in some women. The hormone is still used to treat androgen deficiencies in some men, but it’s rare and is approved for osteoporosis treatment in some postmenopausal women.
